Eli Lilly’s Alzheimer’s Drug Shows Promise in Small Trial The New York TimesLilly hails Alzheimer’s win with donanemab, boasting ‘significant slowing of decline’ FierceBiotechLilly says Alzheimer’s drug slows clinical decline in mid-stage trial ReutersLilly Alzheimer’s Drug Helped Patients in Small Trial The Wall Street JournalLilly’s Donanemab Slows Clinical Decline of Alzheimer’s Disease in Positive Phase 2 Trial PRNewswireView Full Coverage […]
Brain Cells Most Vulnerable to Alzheimer’s Disease Identified by Scientists UCSF News Services Go to News Source
Alarm for Alzheimer’s needs to sound in state, across US Northwest Arkansas Democrat-Gazette Go to News Source
Alzheimer’s disease is a health crisis with no short-term solution: Ken Bravo cleveland.com Go to News Source
Should we keep telling Dad that he has Alzheimer’s? Bemidji Pioneer Go to News Source
Air pollution may contribute to Alzheimer’s and dementia risk – here’s what we’re learning from brain scans The Conversation US Go to News Source
AI gives you a chance to prevent Alzheimer’s Dementia PRNewswire Go to News Source
Industry Voices—Creating an ‘Operation Warp Speed’ for Alzheimer’s FierceHealthcare Go to News Source
According to the Alzheimer’s Association, one in six women over the age of 65 are at risk for developing Alzheimer’s. That’s compared to a one in eleven chance of developing the disease for men of the same age. Put another way, two-thirds of all Americans with Alzheimer’s are women. But why? The simple answer — […]
Alzheimer’s disease is practically unheard of in adults younger than 40, and very rare (one in 2,500) for those under 60. It affects 1 percent of 65-year-olds, 2 percent of 68-year-olds, 3 percent of 70-year-olds. After that, the odds start multiplying.